Biotest AG VZ Stock
Your prediction
Pros and Cons of Biotest AG VZ in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biotest AG VZ vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biotest AG VZ | - | - | - | - | - | - | - |
| MPH Health Care AG | - | 2.752% | -2.609% | -3.448% | 2.283% | 38.700% | -12.157% |
| Pacira Pharmaceuticals | -4.570% | 2.732% | 13.939% | -22.314% | -12.963% | -51.042% | -69.180% |
| Rockwell Medical Inc. | -1.740% | 0.059% | -19.516% | -50.641% | 25.277% | -63.152% | -94.250% |
News
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.